CELUW Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by -0.05% compare to its pairs and should correct downwards.

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases...

Stats
Dzisiejszy wolumen	555
Średni wolumen	0
Kapitalizacja rynkowa	73.87M
EPS	$-4.98 ( Q3 \| 2024-01-03 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0200 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI 3.55%

ABCL -3.79%

ABCM 0.04%

ABEO -5.02%

ABIO -0.29%

ABOS -3.03%

ABSI 0.66%

ABUS 0.66%

ABVX 2.61%

ACAD 3.79%

ACER -17.95%

ACET 9.49%

ACGN 1.29%

ACHL 0.22%

ACHV -4.83%

ACIU 2.47%

ACLX -0.09%

ACRV -5.30%

ACST -0.31%

ACXP -2.15%

ADAG 0.69%

ADAP -1.06%

ADGI 0.87%

ADIL 2.68%

ADMA 0.09%

ADPT 1.54%

ADTX -2.08%

ADVM 1.63%

ADXN -5.75%

AEON -7.34%

AEZS -1.10%

AFMD 1.02%

AGEN 4.60%

AGIO 0.02%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -0.69%

AKRO 2.80%

AKTX -1.08%

AKUS 0.00%

ALBO 0.00%

ALDX -5.46%

ALEC 0.44%

ALGS -4.88%

ALKS -1.28%

ALLK 8.11%

ALLO 2.35%

ALLR -28.40%

ALNA 3.16%

ALNY 34.52%

ALPN 0.02%

ALPX 0.00%

ALRN -1.60%

ALT 11.39%

ALVR 4.92%

ALXN 0.00%

ALXO -0.15%

ALZN -7.26%

AMRN 2.72%

AMTI -3.13%

ANAB 0.21%

ANEB -1.49%

ANGN 0.00%

ANIX -0.79%

ANL 0.29%

ANNX -4.22%

ANPC -3.15%

APGE 2.63%

APGN 8.48%

APGNW 30.65%

APLM 9.95%

APLS 0.92%

APLT 1.76%

APM 1.73%

APOP 0.38%

APRE 3.24%

APTO -2.37%

APTX 3.17%

APVO 1.15%

ARAV -13.39%

ARCT -0.44%

ARDS 2.49%

ARDX 1.46%

ARGX 11.69%

ARNA 0.00%

ARPO -0.90%

ARQT 4.59%

ARTL -2.71%

ARTLW 0.00%

ARVN -0.99%

ARWR 6.82%

ASLN -2.99%

ASMB 0.38%

ASND 1.20%

ATAI 4.48%

ATHA 1.28%

ATHE 2.27%

ATHX -33.50%

ATNF 2.05%

ATOS -5.31%

ATRA 0.67%

ATXI 9.52%

ATXS -2.65%

AUPH 2.35%

AURA -1.25%

AUTL -2.87%

AVBP -0.78%

AVEO 0.00%

AVIR 1.45%

AVRO -1.41%

AVTE -3.85%

AVTX 2.99%

AVXL 3.19%

AXLA 0.00%

AXSM 2.76%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -15.94%

BCAB 3.31%

BCDA -5.67%

BCDAW -39.75%

BCEL 0.00%

BCLI 2.70%

BCRX -2.34%

BCTX -7.44%

BCTXW -18.26%

BCYC 0.10%

BDRX -15.63%

BDTX 0.83%

BEAM 8.24%

BFRA -2.91%

BGNE 1.95%

BIOR 1.50%

BIVI 0.96%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX 3.39%

BLTE 0.27%

BLU 0.03%

BLUE 13.45%

BMEA 5.51%

BMRN 1.62%

BNOX 2.99%

BNTC 4.80%

BNTX 2.33%

BOLD 13.42%

BOLT -1.45%

BPMC 1.79%

BPTH 0.88%

BPTS -13.47%

BRNS 0.00%

BRTX 1.72%

BTAI 4.39%

BTTX 0.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -1.78%

CABA -1.53%

CADL 1.82%

CALA 0.00%

CALC -1.87%

CALT 1.83%

CAPR 1.91%

CARA 22.71%

CARM 9.80%

CASI 7.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -4.40%

CCCC 11.08%

CCXI 0.00%

CDAK 0.00%

CDIO -0.17%

CDIOW 36.86%

CDMO -4.38%

CDMOP 0.04%

CDT -7.05%

CDTTW -23.91%

CDTX -2.84%

CDXC -6.59%

CDXS 2.04%

CELC 4.58%

CELU 0.66%

CELUW 11.18%

CERC -1.68%

CERE -0.55%

CERO 2.09%

CEROW -22.90%

CFRX -27.95%

CGEM -0.34%

CGEN -5.08%

CGON 1.50%

CGTX -2.63%

CHMA -6.00%

CHRS -2.40%

CINC 0.00%

CING 4.73%

CINGW 73.79%

CKPT 15.56%

CLBS -16.75%

CLDX 2.55%

CLGN 6.22%

CLLS 1.06%

CLNN -3.46%

CLNNW -33.25%

CLRB 0.00%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB 8.57%

CMND -7.59%

CMPI 0.00%

CMPX 0.91%

CMRA 0.00%

CMRAW 33.33%

CMRX 1.85%

CNCE 0.00%

CNSP 12.63%

CNST 0.00%

CNTA -2.31%

CNTB -6.25%

CNTX 0.93%

COCP -1.88%

COEPW 0.00%

COGT 1.14%

CORT 1.83%

COYA -2.48%

CPRX -1.28%

CRBP 2.42%

CRBU 8.72%

CRDF -3.67%

CRGX 4.50%

CRIS 3.02%

CRNX 0.18%

CRSP 3.02%

CRTX 2.63%

CRVO 0.40%

CRVS 2.81%

CSBR -1.20%

CTCX -7.84%

CTIC 0.06%

CTMX 3.10%

CTNM 3.23%

CTXR 4.68%

CUE 8.89%

CVAC 6.44%

CVKD 6.24%

CWBR 0.00%

CYAD -12.96%

CYCC -5.01%

CYCCP 4.03%

CYCN 6.69%

CYT -2.27%

CYTK 0.71%

CYTO 2.61%

DARE 1.96%

DAWN -1.10%

DBTX -0.81%

DBVT -1.80%

DFFN 10.28%

DICE 0.06%

DMAC 2.78%

DNLI 1.24%

DNTH -0.04%

DOMH -2.63%

DRMA 12.50%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.62%

DRTSW 0.00%

DRUG -3.77%

DSGN -0.59%

DTIL 0.85%

DYAI -9.66%

EARS -1.77%

EDIT -0.59%

EDSA -0.11%

EFTR -75.81%

EFTRW -96.33%

EIGR -9.21%

ELAB 0.86%

ELDN -4.40%

ELEV -4.30%

ELOX 0.00%

ELTX 6.89%

ELVN 1.87%

ELYM -8.69%

ENGN -9.67%

ENGNW -7.87%

ENLV 3.68%

ENOB 1.79%

ENSC 4.98%

ENTA 2.43%

ENTO -2.13%

ENTX 1.98%

ENVB 9.19%

EPIX -1.02%

EPRX 0.57%

EPZM 0.00%

EQ 2.52%

EQRX -2.09%

EQRXW 0.00%

ERAS 2.37%

ERNA -4.64%

ERYP 1.30%

ESLA -0.50%

ESLAW 0.00%

ETNB -0.82%

ETON -0.60%

ETTX 0.00%

EVAX -5.28%

EVGN -2.18%

EVLO 0.00%

EWTX -1.99%

EXAI -2.78%

EXEL 0.54%

EYEG 0.11%

EYEN 2.28%

EYPT 0.59%

FATE 2.13%

FBIO -3.95%

FBIOP 0.59%

FBLG 5.49%

FBRX 0.27%

FDMT 1.35%

FENC -1.09%

FGEN 6.19%

FHTX 0.38%

FIXX 0.77%

FMTX 0.00%

FNCH -6.77%

FOLD -0.89%

FREQ 4.76%

FRLN 0.15%

FRTX -4.51%

FSTX 0.00%

FTRE -0.65%

FULC -5.09%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -8.97%

GANX 0.00%

GBIO 1.45%

GBT 0.01%

GDTC 5.61%

GERN -1.29%

GHRS 0.42%

GLMD -1.83%

GLPG 1.67%

GLSI -4.73%

GLTO 5.51%

GLUE 4.96%

GLYC 3.61%

GMAB -0.81%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT 1.29%

GNLX 10.68%

GNPX 0.00%

GNTA 7.74%

GOSS 27.09%

GOVX 30.04%

GOVXW 49.24%

GPCR -4.15%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 4.76%

GRTX 40.48%

GTHX -10.48%

GUTS 5.77%

GXGXW 41.67%

GYRE -3.28%

HALO 0.99%

HARP 0.09%

HCWB 10.69%

HEPA 5.42%

HGEN -84.62%

HILS 5.66%

HLVX 2.75%

HOOK -1.07%

HOTH 0.67%

HOWL -9.38%

HRMY -0.10%

HRTX -1.55%

HSTO 0.00%

HUMA -1.35%

HUMAW 5.19%

IBRX 1.10%

ICCC -0.22%

ICPT 0.21%

ICU 10.12%

ICUCW 14.68%

ICVX -0.91%

IDRA -23.04%

IDYA 0.03%

IFRX 8.44%

IGMS 0.00%

IKNA -2.33%

IKT -5.00%

IMAB 2.38%

IMCR -0.28%

IMGN 0.02%

IMGO 0.00%

IMMP -2.92%

IMMX 11.76%

IMNM -4.02%

IMNN -4.46%

IMPL -27.27%

IMRA 15.96%

IMRN 12.11%

IMRX 4.20%

IMTX -1.37%

IMTXW -14.50%

IMUX -0.90%

IMV 0.00%

IMVT 0.18%

INAB -0.84%

INBX 2.18%

INCY 0.84%

INDP -1.33%

INFI -52.38%

INKT -1.62%

INM 9.72%

INMB 1.62%

INO -1.61%

INSM 0.65%

INTS 4.74%

INVA 0.63%

INZY 0.67%

IOBT 0.00%

IONS 6.81%

IOVA 1.87%

IPA -1.92%

IPHA -5.16%

IPSC -6.29%

IRON 1.81%

ISEE 0.38%

ITOS 0.61%

ITRM -5.65%

IVA -0.71%

IVVD 2.42%

JAGX -3.32%

JANX 5.52%

JAZZ 1.72%

JNCE 0.00%

JSPR 1.72%

JSPRW 4.71%

JUNS 0.00%

JUNSW 0.00%

KA 13.13%

KALV -0.17%

KDNY 0.22%

KMPH -0.34%

KNSA 1.40%

KNTE -0.38%

KOD 3.41%

KPRX 9.68%

KPTI 12.76%

KRBP -0.40%

KRON -6.48%

KROS 0.09%

KRRO -0.76%

KRTX 0.03%

KRYS 1.97%

KTRA 6.15%

KTTA 4.85%

KTTAW -5.17%

KURA 0.67%

KYMR -1.69%

KYTX 2.07%

KZIA -15.51%

KZR 1.12%

LABP 0.57%

LBPH 0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.13%

LENZ -1.52%

LEXX -1.49%

LEXXW -0.19%

LGND 0.72%

LGNDV 0.00%

LGVN -12.73%

LIAN -8.28%

LIFE 2.70%

LIPO 10.88%

LIXT -1.57%

LIXTW 0.00%

LJPC -0.32%

LMNL 0.12%

LOGC 1.27%

LPCN 3.56%

LPTX -2.08%

LQDA 3.28%

LRMR -10.33%

LSTA -3.26%

LTRN -5.78%

LUMO 1.79%

LVTX 0.27%

LXEO 4.94%

LXRX -2.16%

LYEL 3.41%

LYRA -2.78%

MACK 0.10%

MBIO 2.70%

MBRX -3.48%

MCRB -2.19%

MDGL 2.00%

MDNA -13.16%

MDWD 7.88%

MDXG -1.02%

MEIP -2.80%

MESO -3.28%

MGNX 2.97%

MGTA -7.74%

MGTX -3.18%

MGX 0.56%

MIRM 8.74%

MIRO 0.59%

MIST 0.72%

MITO 0.00%

MLEC -5.36%

MLECW 90.24%

MLND -5.36%

MLTX 0.73%

MLYS 4.90%

MNKD 6.26%

MNMD 0.27%

MNOV 0.00%

MNPR 15.76%

MOLN -25.10%

MOR -0.11%

MORF 10.26%

MREO -5.53%

MRKR 9.03%

MRNA 2.70%

MRNS 3.01%

MRSN 3.76%

MRTX -0.17%

MRUS 3.77%

MRVI -2.35%

MTCR -1.29%

MTEM -4.59%

MTP -18.50%

MURA -0.62%

MYMD -4.12%

NAMS 8.93%

NAMSW 26.87%

NAUT -8.57%

NBRV 0.71%

NBSE -1.56%

NBTX 4.81%

NCNA -0.34%

NERV -5.52%

NEXI -2.44%

NGM -1.28%

NGNE 2.39%

NKGN 0.00%

NKGNW 8.00%

NKTR 0.86%

NKTX 1.82%

NLSP -5.16%

NLSPW 28.30%

NMRA 0.00%

NMTR -42.97%

NOVN -24.84%

NRBO 0.49%

NRIX -1.27%

NRSN -3.99%

NRSNW 0.00%

NRXP 0.75%

NRXPW 0.00%

NRXS -0.78%

NTBL 0.36%

NTEC -12.45%

NTHI 0.00%

NTLA 3.22%

NTRBW 0.00%

NUVL 1.72%

NVAX 0.14%

NVCT 2.13%

NVIV -34.28%

NXTC 3.70%

NYMX -0.05%

OABI 1.75%

OABIW -3.65%

OBIO 9.02%

OBSV 0.00%

OCEA 7.75%

OCGN -5.26%

OCS 1.37%

OCUL 4.48%

OCUP 1.27%

ODT -4.27%

OKYO -1.63%

OLMA 2.15%

OMER 2.90%

OMGA -0.41%

ONCO -6.85%

ONCR -3.08%

ONCS 31.87%

ONCT -1.85%

ONCY 0.00%

ONTX -0.47%

ONVO -2.28%

OPNT 0.00%

OPT -4.93%

ORGS -3.25%

ORIC -1.11%

ORMP -3.04%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.62%

OVID 1.28%

OYST 0.00%

PALI -3.95%

PASG 0.00%

PBLA -4.76%

PBM -4.74%

PBYI -2.34%

PCSA 0.51%

PCVX 1.12%

PDSB 8.33%

PEPG 4.57%

PGEN 4.55%

PHAR 13.76%

PHAS 0.00%

PHAT -2.26%

PHIO 3.65%

PHIOW 36.47%

PHVS -4.62%

PHXM -5.20%

PIRS -5.56%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 3.28%

PLUR -0.44%

PMN -0.63%

PMVP 4.64%

PNT 0.16%

PPBT 5.78%

PRAX -2.61%

PRDS 0.93%

PRLD 2.88%

PROG -3.47%

PROK -7.60%

PRQR -3.51%

PRTA 0.56%

PRTC -6.90%

PRTG -0.04%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -11.11%

PSTX -1.08%

PTCT -2.05%

PTE -0.82%

PTGX -0.78%

PTIXW -5.10%

PULM -2.53%

PXMD 0.00%

PYPD -1.97%

PYXS -5.34%

QLGN -8.10%

QNCX 0.71%

QNRX 1.44%

QSI 0.84%

QSIAW 1.20%

QTTB -0.71%

QURE -1.09%

RAIN -1.63%

RANI -0.96%

RAPT 3.18%

RARE -0.45%

RCKT 7.03%

REGN 1.02%

RENB 1.27%

REPL 3.06%

RETA 0.02%

REUN -0.89%

REVB 13.74%

REVBU 3.46%

REVBW 50.29%

RGLS -18.33%

RGNX 6.41%

RIGL 0.65%

RLAY -0.58%

RLMD -0.99%

RLYB 5.48%

RNA 1.69%

RNAC 1.05%

RNAZ 5.27%

RNXT 4.09%

ROIV 2.06%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.74%

RPTX 0.28%

RUBY 2.70%

RVLP -32.05%

RVMD 0.76%

RVMDW 17.51%

RVNC -3.38%

RVPH 2.40%

RVPHW 1.92%

RXDX 0.09%

RXRX 5.54%

RYTM 1.58%

RYZB 0.02%

RZLT 7.85%

SABS 4.23%

SABSW -35.81%

SAGE 3.86%

SANA 0.54%

SAVA -1.10%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -6.67%

SCPH 1.24%

SCPS 0.00%

SEEL -2.49%

SEER 1.76%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 5.62%

SGMT 6.87%

SGTX -2.56%

SIOX 22.63%

SLDB 2.48%

SLGL 0.59%

SLN 3.61%

SLNO -2.60%

SLRX -3.97%

SLS -0.82%

SMMT 0.88%

SNDX -1.25%

SNGX -2.31%

SNPX 5.67%

SONN -6.53%

SPPI -0.49%

SPRB 5.39%

SPRC -2.42%

SPRO -2.92%

SRNE 15.79%

SRPT 1.95%

SRRA 0.00%

SRRK -0.47%

SRZN 5.26%

STAB 0.00%

STOK 0.70%

STRO -4.95%

STSA 0.00%

STTK -9.50%

SURF -0.93%

SVRA -5.67%

SWTX -0.17%

SYBX 2.01%

SYRS 4.12%

TALS -0.73%

TARA -1.33%

TARS 1.36%

TBPH 0.23%

TCBP -8.11%

TCDA 0.00%

TCON -1.60%

TCRR 0.00%

TCRT -3.84%

TCRX 2.92%

TECH 1.13%

TENX 9.03%

TERN 4.01%

TFFP 9.20%

TGTX 4.31%

THRX 0.12%

TIL -3.68%

TLC 0.00%

TLSA 14.49%

TNGX 0.50%

TNXP -8.46%

TNYA -0.96%

TPST 2.96%

TRDA -4.11%

TRVI -2.22%

TRVN -13.99%

TSHA -10.14%

TSVT 3.76%

TTNP -14.84%

TVTX 6.57%

TYRA 0.35%

UBX 0.36%

UNCY 7.44%

URGN 5.81%

UTHR 0.92%

VACC 11.36%

VALN 12.99%

VAXX -10.53%

VBIV 3.44%

VBLT -8.77%

VCEL 2.64%

VCNX -0.49%

VCYT 1.77%

VERA -2.79%

VERU 9.04%

VERV -0.19%

VIGL 0.52%

VINC -1.38%

VIR 0.22%

VIRI -1.85%

VIRX -5.63%

VKTX -1.18%

VLON -13.04%

VNDA -2.29%

VOR 4.20%

VRCA -4.56%

VRDN 5.09%

VRNA 4.60%

VRPX -4.95%

VRTX 1.33%

VSTM -1.90%

VTGN -3.58%

VTVT 0.00%

VTYX -0.80%

VXRT 5.82%

VYGR -0.43%

VYNE -4.95%

VYNT 7.78%

WINT 7.90%

WVE -0.76%

XBIO -5.83%

XBIT -12.02%

XCUR -3.35%

XENE -0.21%

XERS 0.00%

XFOR 0.00%

XLO 2.47%

XLRN 0.00%

XNCR 1.46%

XOMA 5.64%

XOMAO -0.20%

XOMAP -0.76%

XRTX -2.38%

YMAB 0.83%

ZGNX 0.00%

ZIOP -0.88%

ZLAB 0.97%

ZNTL -3.16%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-01-12	Lim Kok Thay	Buy	21 410 983	Class A Common Stock
2024-01-12	Lim Kok Thay	Buy	16 500 000	Warrants (Right to Buy)
2024-01-12	Lim Kok Thay	Buy	6 529 818	Warrants (Right to Buy)
2024-01-12	Lim Kok Thay	Buy	5 352 746	Warrants (Right to Buy)
2024-01-12	Lim Kok Thay	Sell	6 529 818	Warrants (Right to Buy)

INSIDER POWER
55.85
Last 92 transactions
Buy: 110 408 052 \| Sell: 53 673 583

Korelacja (AI algo v.1.1b): Overvalued: -0.05% $0.0179 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Celularity Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Celularity Inc. Finanse

Annual	2022
Przychody:	$17.98M
Zysk brutto:	$-1.69M (-9.40 %)
EPS:	$1.010

FY	2022
Przychody:	$17.98M
Zysk brutto:	$-1.69M (-9.40 %)
EPS:	$1.010

FY	2021
Przychody:	$21.34M
Zysk brutto:	$11.68M (54.76 %)
EPS:	$-0.00100

FY	2020
Przychody:	$14.28M
Zysk brutto:	$9.35M (65.46 %)
EPS:	$-0.0000335

Financial Reports:

No articles found.

Celularity Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Celularity Inc.

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company\'s lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn\'s disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.